🚀 VC round data is live in beta, check it out!
Jana Medical Company Valuation Multiples
Discover revenue and EBITDA valuation multiples for Jana Medical Company and similar public comparables like Spineguard, Bionano Genomics, Scandinavian Real Heart, Arcoma and more.
Jana Medical Company Overview
About Jana Medical Company
Jana Medical Co is engaged in the medical sector. The company is in the field of medical supplies and devices for anesthesia, cardiac surgeries, respiratory therapy supplies, neurosurgery, spine, ear, nose, and throat represented in the Excellent Medical Care Company and the Elite Medical Company.
Founded
2015
HQ
Employees
53
Website
Sectors
Financials (FY)
EV
$8M
Jana Medical Company Financials
Jana Medical Company reported last fiscal year revenue of $10M and negative EBITDA of ($4M).
In the same fiscal year, Jana Medical Company generated $4M in gross profit, ($4M) in EBITDA losses, and had net loss of ($6M).
Jana Medical Company P&L
In the most recent fiscal year, Jana Medical Company reported revenue of $10M and EBITDA of ($4M).
Jana Medical Company expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $10M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $4M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 46% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($4M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (37%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (14%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($6M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (63%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Jana Medical Company Stock Performance
Jana Medical Company has current market cap of $12M, and enterprise value of $8M.
Market Cap Evolution
Jana Medical Company's stock price is $3.79.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8M | $12M | 0.0% | XXX | XXX | XXX | $-1.92 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialJana Medical Company Valuation Multiples
Jana Medical Company trades at 0.8x EV/Revenue multiple, and (2.1x) EV/EBITDA.
Jana Medical Company Financial Valuation Multiples
As of April 11, 2026, Jana Medical Company has market cap of $12M and EV of $8M.
Equity research analysts estimate Jana Medical Company's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Jana Medical Company has a P/E ratio of (2.0x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $12M | XXX | $12M | XXX | XXX | XXX |
| EV (current) | $8M | XXX | $8M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (2.1x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (5.5x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 1.7x | XXX | XXX | XXX |
| P/E | — | XXX | (2.0x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | 5.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Jana Medical Company Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Jana Medical Company Margins & Growth Rates
Jana Medical Company's revenue in the last fiscal year declined by (40%).
Jana Medical Company's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Jana Medical Company Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (40%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (37%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (214%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 10% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 60% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Jana Medical Company Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Spineguard | XXX | XXX | XXX | XXX | XXX | XXX |
| Bionano Genomics | XXX | XXX | XXX | XXX | XXX | XXX |
| Scandinavian Real Heart | XXX | XXX | XXX | XXX | XXX | XXX |
| Arcoma | XXX | XXX | XXX | XXX | XXX | XXX |
| Renalytix | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Jana Medical Company M&A Activity
Jana Medical Company acquired XXX companies to date.
Last acquisition by Jana Medical Company was on XXXXXXXX, XXXXX. Jana Medical Company acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Jana Medical Company
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialJana Medical Company Investment Activity
Jana Medical Company invested in XXX companies to date.
Jana Medical Company made its latest investment on XXXXXXXX, XXXXX. Jana Medical Company invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Jana Medical Company
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Jana Medical Company
| When was Jana Medical Company founded? | Jana Medical Company was founded in 2015. |
| Where is Jana Medical Company headquartered? | Jana Medical Company is headquartered in Saudi Arabia. |
| How many employees does Jana Medical Company have? | As of today, Jana Medical Company has over 53 employees. |
| Is Jana Medical Company publicly listed? | Yes, Jana Medical Company is a public company listed on Tadawul. |
| What is the stock symbol of Jana Medical Company? | Jana Medical Company trades under 9616 ticker. |
| When did Jana Medical Company go public? | Jana Medical Company went public in 2024. |
| Who are competitors of Jana Medical Company? | Jana Medical Company main competitors are Spineguard, Bionano Genomics, Scandinavian Real Heart, Arcoma. |
| What is the current market cap of Jana Medical Company? | Jana Medical Company's current market cap is $12M. |
| What is the current revenue of Jana Medical Company? | Jana Medical Company's last fiscal year revenue is $10M. |
| What is the current EV/Revenue multiple of Jana Medical Company? | Current revenue multiple of Jana Medical Company is 0.8x. |
| Is Jana Medical Company profitable? | No, Jana Medical Company is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.